Advertisement

Topics

Innovator or Generic, All Roads Lead to the 505(b)(2)

06:00 EDT 7 Aug 2017 | Net Resources International

Faced with decreasing R&D output, billions of dollars in patent expirations and increasing generic competition, innovators are forced to re-evaluate traditional business models.

Original Article: Innovator or Generic, All Roads Lead to the 505(b)(2)

NEXT ARTICLE

More From BioPortfolio on "Innovator or Generic, All Roads Lead to the 505(b)(2)"

Quick Search
Advertisement
 

Relevant Topic

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...